Clinical Trial Update: A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two clobetasol propionate 0.05% formulations (Clobex spray vs Olux foam) in psoriasis patients; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Clobetasol Propionate 0.05% (Clobex Spray) (clobetasol propionate)
• Clobetasol Propionate 0.05% (Olux Foam) (clobetasol propionate)

Snippet

Sponsor: Galderma R&D | Conditions: Psoriasis | Phase 4 | Status: COMPLETED